10:06 AM EST - MediPharm Labs Corp. : And Argentia Gold Corporation, a Canadian vertically-integrated licensed producer, today announced the formation of a supply arrangement to bring premium cannabis-infused products to Atlantic Canada. Under the agreement, which has an initial two-year term, MediPharm Labs will provide Argentia Gold-branded formulated tincture bottles of CBD cannabis resin and Argentia Gold will provide distribution, sales, and service to leading retailers in Newfoundland and Labrador, Prince Edward Island, Nova Scotia and New Brunswick. MediPharm Labs Corp.
shares T.LABS are trading down $0.03 at $1.88.
